Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models-Reference-Cited by-同舟云学术

Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models

Published:2011-08 Issue:22 Volume:32 Page:5252-5261
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Na Jin Hee,Koo Heebeom,Lee Sangmin,Min Kyung Hyun,Park Kyeongsoon,Yoo Heon,Lee Seung Hoon,Park Jae Hyung,Kwon Ick Chan,Jeong Seo Young,Kim Kwangmeyung

Funder

National R&D Program for Cancer Control of Ministry for Health and Welfare

Fusion Technology Project

Intramural Research Program (Theragnosis)

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference36 articles.

1. Nanoparticles in cancer therapy and diagnosis;Brigger;Adv Drug Deliv Rev,2002

2. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat Nanotechnol,2007

3. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model;Arap;Science,1998

4. Strategies in the design of nanoparticles for therapeutic applications;Petros;Nat Rev Drug Discov,2010

5. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy;Papahadjopoulos;Proc Natl Acad Sci U S A,1991

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancement of hybrid nanoparticles synthesis and applications in lung cancer management;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

2. Chitosan nanoparticles for gene delivery in cancer therapy and disease diagnosis;Cancer Therapy;2024

3. All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy;Bioactive Materials;2023-10

4. Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood–Brain Barrier to Treat Brain Tumors;Pharmaceutics;2023-06-23

5. Inhibition of epithelial‐to‐mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinoma;The FEBS Journal;2023-06-10